Fengxia Xue

11PUBLICATIONS
46CO-AUTHORS
Foetal development and medicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 11, 2026
Hyperadhesive von Willebrand Factor Contributes to Pathogenesis of Preeclampsia.

|Jun 14, 2024
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.

Xiaohua Wu, Jihong Liu, Ruifang An

|Jul 27, 2022
CBX8 Together with SET Facilitates Ovarian Carcinoma Growth and Metastasis by Suppressing the Transcription of SUSD2.

Yanjie Wu, Yang Duan, Xuanyuan Li

|Aug 16, 2021
Endometrial cancer in Lynch syndrome.

Shuangshuang Zhao, Lingli Chen, Yuqin Zang

|Jul 12, 2021
IK: A novel cell mitosis regulator that contributes to carcinogenesis.

Chao Gao, Yanyan Han, Lu Bai

|Apr 08, 2019
Reply to comments on "Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies".

Xuegong Ma, Yingmei Wang, Fengxia Xue

Pageof 2

Frequent Collaborators

2 joint publications

Yingmei Wang

1 joint publications

Yanjie Wu

1 joint publications

Yang Duan

1 joint publications

Xuanyuan Li